Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Vaccines market was valued at 33726 Million US$ in 2018 and is projected to reach 56111 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.57% during the forecast period.
This report presents the market size and development trends by detailing the Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Vaccines industry and will help you to build a panoramic view of the industrial development.
Vaccines Market, By Type:
Inactivated vaccines
DNA vaccines
Attenuated vaccines
Subunit vaccines
Conjugate vaccines
Toxoid vaccines
Others
Vaccines Market, By Application:
Infectious diseases
Cancer
Autism
Allergy
Others
Some of the leading players are as follows:
Takeda Pharmaceuticals
Emergent BioSolutions
GlaxoSmithKline plc.
SANOFI S.A
SANOFI SA.
Merck & Co Inc
Astellas Pharma Inc
NOVARTIS AG
Merck & Co. Inc
AstraZeneca
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Vaccines Market: Technology Type Analysis
-
4.1 Vaccines Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Vaccines Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Inactivated vaccines
4.3.2 DNA vaccines
4.3.3 Attenuated vaccines
4.3.4 Subunit vaccines
4.3.5 Conjugate vaccines
4.3.6 Toxoid vaccines
4.3.7 Others
5 Vaccines Market: Product Analysis
-
5.1 Vaccines Product Market Share Analysis, 2018 & 2026
-
5.2 Vaccines Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Vaccines Market: Application Analysis
-
6.1 Vaccines Application Market Share Analysis, 2018 & 2026
-
6.2 Vaccines Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Infectious diseases
6.3.2 Cancer
6.3.3 Autism
6.3.4 Allergy
6.3.5 Others
7 Vaccines Market: Regional Analysis
-
7.1 Vaccines Regional Market Share Analysis, 2018 & 2026
-
7.2 Vaccines Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Emergent BioSolutions
9.2.1 Emergent BioSolutions Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GlaxoSmithKline plc.
9.3.1 GlaxoSmithKline plc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 SANOFI S.A
9.4.1 SANOFI S.A Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 SANOFI SA.
9.5.1 SANOFI SA. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Merck & Co Inc
9.6.1 Merck & Co Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Astellas Pharma Inc
9.7.1 Astellas Pharma Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 NOVARTIS AG
9.8.1 NOVARTIS AG Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck & Co. Inc
9.9.1 Merck & Co. Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 AstraZeneca
9.10.1 AstraZeneca Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 141 Tables)
Figure Inactivated vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure DNA vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure Attenuated vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure Subunit vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure Conjugate vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure Toxoid vaccines Vaccines market, 2015 - 2026 (USD Million)
Figure Others Vaccines market, 2015 - 2026 (USD Million)
Figure Infectious diseases market, 2015 - 2026 (USD Million)
Figure Cancer market, 2015 - 2026 (USD Million)
Figure Autism market, 2015 - 2026 (USD Million)
Figure Allergy market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table North America Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table North America Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table North America Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Canada Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Canada Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Europe Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Europe Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Europe Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Europe Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Germany Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Germany Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table France Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table France Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Italy Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Italy Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Spain Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Spain Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table China Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table China Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Japan Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Japan Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table India Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table India Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table MEA Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table MEA Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table MEA Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table MEA Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Takeda Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emergent BioSolutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline plc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SANOFI S.A Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SANOFI SA. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astellas Pharma Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NOVARTIS AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co. Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
